13 results about "Captopril" patented technology

The invention relates to the technical field of catalyst preparation, in particular to a supported TBD-IPTS / SBA-15 catalyst and a preparation method and application thereof.The preparation method comprises the following steps that an SBA-15 carrier is treated with acid liquor, washed to be neutral and then dried, and an activated carrier SBA-15-OH is obtained; the preparation method comprises the following steps: dispersing SBA-15-OH in anhydrous toluene under the protection of nitrogen, adding IPTS (isopropyl-beta-d-thiosulfate) for reflux reaction, and washing and drying after the reaction is finished to obtain IPTS / SBA-15; iPTS / SBA-15 is dispersed in anhydrous dichloromethane, a TBD solution is added for a reaction, washing and drying are performed after the reaction is finished, and a supported TBD-IPTS / SBA-15 catalyst is obtained; the problems that in existing captopril intermediate synthesis, a by-product L-MAT is difficult to utilize, a traditional homogeneous TBD catalyst is difficult to recycle and reuse, and in an existing loading technology, active components are poor in stability and low in catalytic efficiency are solved.

The present application relates to a kind of monodisperse core-shell type hybrid silica microspheres containing vinyl shell and its preparation and application. Specifically, using "two-phase method" strategy, monodisperse solid silica microspheres are used as matrix, vinyl triethoxysilane and tetraethyl orthosilicate are used as raw materials, lauryl amide propyl betaine and sodium subtiliporin are used as double-template pore-forming agent, under the catalysis of urea, sol-gel reaction occurs, a layer of porous hybrid shell containing vinyl functional group is constructed on the surface of solid silica microspheres, and core-shell type silica hybrid microspheres are formed. Because the shell contains a large number of vinyl functional groups, after hydrophilic modification with captopril, it is used as the adsorbent of hydrophilic interaction chromatography, and is applied to the selective enrichment of biological samples. The core-shell type silica hybrid microspheres prepared in the present application have uniform morphology, good monodispersity, and rich vinyl functional groups on the surface, which are easy to modify and apply subsequently.

This invention discloses an octapeptide derived from soybean protein with the function of lowering blood pressure, blood sugar, and cholesterol, as well as its preparation and application, belonging to the field of small molecule peptide technology. The octapeptide sequence is YEGNWGPL, which can be obtained artificially or by targeted enzymatic hydrolysis of soybean protein isolate. Functional verification in a hyperlipidemia model shows that the octapeptide YEGNWGPL has the function of lowering blood lipids; functional verification in a hyperglycemia model shows that the octapeptide YEGNWGPL has the function of lowering blood sugar, with a significantly better effect than the drug metformin; functional verification in a hypertension model shows that the octapeptide YEGNWGPL has the function of lowering blood pressure, with a significantly better effect than the antihypertensive drug captopril; moreover, food-derived bioactive peptides have high biosafety, therefore, they can be applied to the development of related products for lowering blood pressure, blood sugar, and cholesterol or assisting in lowering blood pressure, blood sugar, and cholesterol, with good market prospects and application potential.

The invention discloses cordyceps sobolifera polysaccharide with an effect of reducing blood pressure and a microbial fermentation preparation method of the cordyceps sobolifera polysaccharide, and belongs to the field of preparation and application of fungal polysaccharide extracts. The cordyceps sobolifera polysaccharide is prepared by adopting a microbial fermentation method, cordyceps sobolifera coremium is used as a fermentation substrate, plant lactobacillus is used as a fermentation strain, liquid fermentation extraction is performed to obtain the cordyceps sobolifera polysaccharide CCP-Lp, the monosaccharide composition and the molar ratio of mannose to glucose to galactose are 1: 0.36: 0.62, and the relative molecular mass is 1.32 * 10 < 5 > Da. Efficacy experiments show that CCP-Lp can significantly inhibit abnormal increase of systolic pressure and diastolic pressure of spontaneously hypertensive rats and regulate the key factor level of a renin-angiotensin-aldosterone system, and the antihypertensive effect of CCP-Lp can be comparable with that of a positive drug captopril. The cordyceps sobolifera polysaccharide CCP-Lp is clear in composition and remarkable in effect, and has wide development and application prospects in the aspect of blood pressure regulation and control.

The application discloses a cordyceps cicadae and cordyceps sinensis polysaccharide with blood pressure lowering efficacy and a microbial fermentation preparation method thereof, and belongs to the field of fungal polysaccharide extract preparation and application. The cordyceps cicadae and cordyceps sinensis polysaccharide is prepared by a microbial fermentation method, a cordyceps cicadae and cordyceps sinensis spore bundle is used as a fermentation matrix, and bacillus lactis is used as a fermentation strain; after liquid fermentation extraction, the cordyceps cicadae and cordyceps sinensis polysaccharide CCP-Lp is obtained, the monosaccharide composition and molar ratio of which are as follows: mannose: glucose: galactose = 1: 0.36: 0.62, and the relative molecular mass is 1.32*10 5 Da. Efficacy experiments show that the CCP-Lp can significantly inhibit abnormal increase of systolic pressure and diastolic pressure of spontaneous hypertension rats, and regulate levels of key factors of a renin-angiotensin-aldosterone system; the antihypertensive effect of the CCP-Lp is comparable to that of a positive drug, captopril. The cordyceps cicadae and cordyceps sinensis polysaccharide CCP-Lp has clear composition and significant efficacy, and has a broad development and application prospect in regulating blood pressure.

This invention discloses a soybean protein small molecule peptide with the effect of lowering blood pressure, blood sugar, and cholesterol, as well as its preparation and application, belonging to the field of small molecule peptide technology. The soybean protein small molecule peptide is obtained by targeted enzymatic hydrolysis of soybean protein isolate, containing the bioactive peptide PLEGFPF with the effect of lowering blood pressure, blood sugar, and cholesterol. Functional verification shows that the bioactive peptide PLEGFPF and the soybean protein small molecule peptide containing this peptide have the function of lowering blood lipids; it has the function of lowering blood sugar, with a lower effective concentration and better effect compared with the positive drug metformin; it has the function of lowering blood pressure, with a lower effective concentration and better effect compared with the positive drug captopril. Food-derived bioactive peptides have high biosafety; therefore, they can be applied to the development of related products for lowering or assisting in lowering blood pressure, blood sugar, and cholesterol, with good market prospects and application potential.

This invention discloses a casein-derived small molecule peptide with antihypertensive effect and its preparation method, belonging to the field of bioactive peptide technology. The preparation method is as follows: S1, mix casein with water and stir until homogeneous; S2, add a complex protease for enzymatic hydrolysis, then add bromelain for further enzymatic hydrolysis to inactivate the enzyme; S3, centrifuge the mixture; S4, heat the separated mixture, add activated carbon for adsorption, then add diatomaceous earth, stir until homogeneous, and filter; S5, further filter through a membrane; S6, concentrate the mixture, sterilize, and dry to obtain the casein-derived small molecule peptide. The casein-derived small molecule peptide of this invention can effectively lower blood pressure by inhibiting ACE activity and blocking the production of angiotensin II. This small molecule peptide significantly increases blood flow activity and angiotensin II content in a hypertensive model zebrafish, exhibiting a dose-dependent effect, achieving the same effect as the antihypertensive drug captopril, and with an efficacy concentration that is half that of the positive control drug.

The invention relates to the field of biological medicine, in particular to a three-component platinum (IV) complex containing captopril (CTP) and valproic acid (VPA), a preparation method of the three-component platinum (IV) complex and application of the three-component platinum (IV) complex in preparation of anti-tumor proliferation and anti-metastasis drugs. The anti-tumor proliferation and anti-metastasis effects of the target compound are tested through in-vivo and in-vitro testing means, and the anti-tumor mechanism of the medicine is researched. Results prove that the compound has a remarkable anti-tumor capability, particularly has an excellent treatment effect on metastatic malignant tumors, is expected to provide a new candidate drug for clinical treatment of tumors, and provides a new direction for research and development of novel platinum drugs and anti-tumor metastasis drugs.

The invention discloses Mopan persimmon polypolyphenol series sulfydryl flavanol derivatives as well as a preparation method and application thereof, belongs to the technical field of plant polypolyphenol component degradation and degradation product separation and preparation and the technical field of biological medicines, and particularly relates to preparation of 16 series sulfydryl flavanol derivatives and application of the 16 series sulfydryl flavanol derivatives in the anti-inflammatory aspect. Based on an oriented transformation strategy of a functionalized nucleophilic reagent, a reaction reagent with a characteristic functional group is introduced, and a structure-activity oriented degradation reaction system is constructed. The method comprises the following steps: by taking Mopan persimmon fruit poly-polyphenol extract as a raw material and methanol as a solvent under an acid catalysis condition, degrading a persimmon fruit poly-polyphenol extracting solution into extension units containing carbocations, and respectively combining the extension units with captopril, L-cysteine, N-acetylcysteine and glutathione to generate a series of sulfydryl flavanol derivatives. The sulfydryl flavanol derivative disclosed by the invention has obvious anti-inflammatory activity and can be used for preparing anti-inflammatory drugs.

The invention discloses a detection method for determining isomers in captopril. The isomers comprise a chiral isomer 1, a chiral isomer 2 and a chiral isomer 3. According to the detection method, a high performance liquid chromatograph is used, a mobile phase is a mixed solution, and isocratic elution is adopted; the invention provides a detection method for simultaneously determining three chiral isomers in captopril by adopting a high performance liquid chromatograph according to the structural characteristics of a product and the properties of a compound. The isocratic chromatographic conditions are adopted, each chiral isomer and captopril can be effectively separated, the detection sensitivity and accuracy of each component are further improved by optimizing the conditions, the limit requirements of each impurity are met, and the detection cost and the operation difficulty are greatly reduced.

This application discloses a method for detecting skin-whitening ingredients. Specifically, it provides a method for detecting skin-whitening ingredients, including carbimazole, 5-N-propyluracil, or peptide-amidazoline in cosmetics, filling the gap in existing technologies that lack methods for detecting these ingredients in cosmetics. This application also provides a high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS / MS) method for detecting nine substances—methimazole, carbimazole, thiouracil, methylthiouracil, 5-N-propyluracil, propylthiouracil, captopril, ethionamide, and peptide-amidazoline—in a sample. This method is simple to operate, rapid, highly specific, and has high resolution. It can be used as a detection method for the above nine ingredients in cosmetics, food, pharmaceuticals, and health products, providing technical support for the analysis of prohibited substances and other substances in related categories in cosmetics.

The invention relates to a hybridoma cell strain secreting an anti-captopril monoclonal antibody and application of the hybridoma cell strain, and belongs to the technical field of drug safety immunoassay. The hybridoma cell strain secreting the anti-monoclonal antibody is preserved in China General Microbiological Culture Collection Center (CGMCC) on the year, the preservation number is CGMCC No.46502, the preservation address is No.3, Yard 1, Beichen West Road, Chaoyang District, Beijing, and the hybridoma cell strain is classified and named as a monoclonal cell strain. The captopril monoclonal antibody cell strain obtained by the invention can be used for drug quality detection and captopril residue detection in a biological sample, has better detection sensitivity (IC50 value is 3.433 ng / mL) and specificity (the cross-over rate for related structural analogues is less than 1%) to captopril, and can realize detection of captopril in drugs and biological samples; and an efficient immunodetection tool is provided for clinical medication detection and drug quality control, the clinical medication safety and effectiveness are guaranteed in an assisted manner, and the kit has a definite practical application value.

1. The name of the design product: packaging box (compound captopril tablet). 2. The use of the design product: a packaging box for packaging medicine. 3. The design points of the design product: in the pattern. 4. The picture or photo that best indicates the design points: perspective drawing.